Quick Takeaways
- Dipal Doshi has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $6,454,258.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Dipal Doshi
- Location
- Cranbury, NJ
- Summary
- The estimated net worth of Dipal Doshi is at least $6,454,258 dollars as of 03 Mar 2026. Dipal Doshi is the CEO, Director of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $6.18M. Dipal Doshi is the Director of Azenta, Inc. and owns shares of Azenta, Inc. (AZTA) stock worth about $270.2K.
- Signature
- /s/ Jared Cohen, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Dipal Doshi and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Entrada Therapeutics, Inc. ($6,184,030).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Dipal Doshi
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics, Inc. | CEO, Director | $6,184,030 | 01 Mar 2026 | ||
| AZTA | Azenta, Inc. | Director | $270,228 | 05 Feb 2026 |
Insider Transactions Reported by Dipal Doshi:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.